Lunai Bioworks (LNAI) Cash from Operations (2011 - 2026)
Lunai Bioworks (LNAI) recorded quarterly Cash from Operations of 1026856.0 in Q1 2026, up 4.14% quarter-over-quarter from 1071213.0 in Q4 2025, and up 30.97% on a YoY basis from 784064.47 in Q1 2025.
Lunai Bioworks (LNAI) Cash from Operations (2011 - 2026) Analysis & Trends
Lunai Bioworks' Cash from Operations history runs 16 years deep, the most recent figure standing at 1026856.0 for Q1 2026.
- In Q1 2026, Cash from Operations rose 30.97% year-over-year to 1026856.0; the TTM figure through Mar 2026 stood at 5258315.0 (up 37.97% YoY), while the FY2025 annual figure was 7874647.0, up 28.23% from the prior year.
- Cash from Operations was 1026856.0 for Q1 2026 at Lunai Bioworks, up from 1071213.0 in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of 1026856.0 in Q1 2026 to a low of 3551471.0 in Q4 2022.
- Historically, Cash from Operations has averaged 2347234.71 across 5 years, with a median of 2559724.0 in 2024.
- Biggest YoY gain for Cash from Operations was 76.59% in 2022; the steepest drop was 19.47% in 2022.
- A 5-year view of Cash from Operations shows it stood at 3551471.0 in 2022, then increased by 11.4% to 3146623.0 in 2023, then climbed by 18.65% to 2559724.0 in 2024, then soared by 58.15% to 1071213.0 in 2025, then rose by 4.14% to 1026856.0 in 2026.
- The last three Cash from Operations figures came in at 1026856.0 (Q1 2026), 1071213.0 (Q4 2025), and 1349110.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -1.67 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -12.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.49 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.43 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Lunai Bioworks | 95.85 Mn | 92.70 Mn | 20,942.00 | -1.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.03 Mn |
| Mar 31, 2026 | -1.03 Mn |
| Dec 31, 2025 | -1.07 Mn |
| Dec 31, 2025 | -1.07 Mn |
| Sep 30, 2025 | -1.35 Mn |
| Sep 30, 2025 | -1.35 Mn |
| Jun 30, 2025 | -1.81 Mn |
| Jun 30, 2025 | -1.81 Mn |
| Mar 31, 2025 | -1.49 Mn |
| Mar 31, 2025 | -1.49 Mn |
| Dec 31, 2024 | -2.56 Mn |
| Dec 31, 2024 | -2.56 Mn |
| Sep 30, 2024 | -2.02 Mn |
| Sep 30, 2024 | -2.02 Mn |
| Jun 30, 2024 | -2.41 Mn |
| Jun 30, 2024 | -2.41 Mn |
| Mar 31, 2024 | -2.63 Mn |
| Mar 31, 2024 | -2.63 Mn |
| Dec 31, 2023 | -3.15 Mn |
| Dec 31, 2023 | -3.15 Mn |